IL18 and lung cancer: Conversely, others reported that NLRP3 inflammasome activation and the consequent release of IL-1β and IL-18 promoted tumor growth, proliferation, invasion, and metastasis in lung cancer, melanoma, breast cancer, and head and neck squamous cell carcinoma [129].